Abstract:Neuropsychiatric disorders affect millions of people globally. Despite their high prevalence, the precise molecular mechanisms behind these conditions remain largely unclear. A complex interplay of genetic, developmental, and environmental factors may increase susceptibility to these disorders, with specific molecular changes potentially influencing disease onset and progression. Understanding these molecular pathways is crucial for deepening our knowledge of neuropsychiatric pathophysiology and for developing targeted therapies. The Research Topic Molecular Mechanisms of Neuropsychiatric Diseases is the second volume and the continuation of the first volume [1], being created in response to the high interest and positive reception it received in the first volume.This research collection aims to uncover key molecular mechanisms in neuropsychiatric disorders and explore how they might inform therapeutic strategies. The progress in understanding these disorders has been slowed by a lack of clear anatomical and molecular mechanism understanding.The papers in this collection address these obstacles by connecting signs and symptoms to underlying anatomical and molecular alterations.The review by Azevedo et al examines how the activation of the sympathoadrenal medullary system and the hypothalamic-pituitary-adrenal axis in response to stress impacts memory formation, particularly in fear and traumatic memories linked to post-traumatic stress disorder (PTSD).Catecholamines like norepinephrine (NE) and epinephrine (EPI) play key roles in adaptive responses to stress and are involved in contextual fear memory enhancement through β2-adrenoceptor (β2-AR) activation [2], influencing the brain via the vagus nerve and blood glucose changes [3,4]. This review highlights that EPI is particularly influential in fear memories, activating the hippocampal Nr4a2 mRNA expression related to cAMP response element-binding protein (CREB), which plays a significant role in contextual fear memory consolidation under stressful conditions [5]. An imbalance in this system, especially over-active sympathetic responses, contributes to the persistence of traumatic memories in PTSD, with some patients [6] and animal PTSD models showing elevated catecholamine levels [7]. The authors suggest that treatments such as sotalol, a β-AR blocker [8], and nepicastat, a dopamine β-hydroxylase inhibitor [9], could reduce PTSD risk by preventing the consolidation of traumatic memories. These drugs appear to regulate gene expression in the hippocampus (Nr4a, Npas4 or Bdnf), potentially fostering more neutral contextual memories [8,9]. These treatment approaches, combined with therapy, may help PTSD patients build resilience and cope with trauma by down-regulating excessive catecholamine effects and dysregulated gene activity.A brief research report article by Bartsch et al investigates how traumatic stress leads to persistent neural changes, focusing on synaptic plasticity in a pathway between the neurons of the posterior ventral segment of the medial amygdala and the ventrolateral segment of the ventromedial hypothalamus. Using the mGRASP imaging technique, researchers observed an increase in synapse formation in this pathway in mice exposed to acute stress compared to controls. Chemogenetic inhibition of CaMKIIα-expressing neurons in the medial amygdala during stress reduced these synaptic changes, suggesting excitatory activity drives this plasticity. Additionally, blocking NMDA receptors prevented stress-induced synapse formation, highlighting an NMDA receptor-dependent mechanism. These structural changes in the medial amygdala and the ventromedial hypothalamus pathway may underlie lasting behavioural effects of traumatic stress, such as those seen in PTSD and social behaviour changes, shedding light on potential targets for intervention.affects stress responses, highlighting the role of dopaminergic neurotransmission in stress susceptibility and resilience. Researchers compared wild-type (WT) and DAT-knockout (KO) mice under chronic stress, observing that DAT-KO mice showed resistance to stress-related anxiety behaviours. These findings suggest that loss of DAT may protect against stress-induced anxiety-like behaviours, underscoring the significance of dopamine pathways in stress resilience.gene, which encodes a subunit of the GABAB receptor (GABABR) critical for inhibitory neurotransmission in the brain, impact receptor structure and function. A 7-year-old boy with Level 3 Autism Spectrum Disorder was found to carry a de novo GABBR2 p.Arg212Gln variant, identified as a variant of unknown significance via whole exome sequencing. Although treatment with the GABABR agonist baclofen showed no improvement, researchers investigated whether this variant might contribute to patient`s symptoms. Using molecular dynamics simulations and in vitro experiments, they studied how the p.Arg212Gln variant, along with -Abstract Truncated-

Human Variants in the Neuronal Basic Helix-Loop-Helix/Per-Arnt-Sim (bHLH/PAS) Transcription Factor Complex NPAS4/ARNT2 Disrupt Function

Transcriptional regulation of neurodevelopmental and metabolic pathways by NPAS3

Npas3 Deficiency Impairs Cortical Astrogenesis and Induces Autistic-Like Behaviors

Reciprocal regulation of the basic helix–loop–helix/Per–Arnt–Sim partner proteins, Arnt and Arnt2, during neuronal differentiation

Disruption of a brain transcription factor, NPAS3, is associated with schizophrenia and learning disability

A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density

Sexual divergence in activity-dependent neuroprotective protein impacting autism, schizophrenia, and Alzheimer's disease

A NPAS4–NuA4 complex couples synaptic activity to DNA repair

LARP1 haploinsufficiency is associated with an autosomal dominant neurodevelopmental disorder

Sleep and diurnal alternative polyadenylation sites associated with human APA-linked brain disorders

Editorial: Molecular mechanisms of neuropsychiatric diseases, volume II

ZMYND11 Functions in Bimodal Regulation of Latent Genes and Brain-like Splicing to Safeguard Corticogenesis

Human SYNGAP1 Regulates the Development of Neuronal Activity by Controlling Dendritic and Synaptic Maturation

Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans

A Frameshift Variant of GluN2A Identified in an Epilepsy Patient Results in NMDA Receptor Mistargeting

Dynamic Regulation Of The Chromatin Environment By ASH1L Modulates Human Neuronal Structure And Function

PAC1R Genotype to Phenotype Correlations in Autism Spectrum Disorder

A Promoter Variant in ZNF804A Decreasing Its Expression Increases the Risk of Autism Spectrum Disorder in the Han Chinese Population

Abstract 11643: ACTN4 Regulates HLA-DPA1-Related Pulmonary Endothelial Pathophenotypes in Pulmonary Arterial Hypertension Through Allele-Specific Binding to Functional SNP rs9277336

Novel ADNP Syndrome Mice Reveal Dramatic Sex-Specific Peripheral Gene Expression With Brain Synaptic and Tau Pathologies

Analyses of the Autism-Associated Neuroligin-3 R451C Mutation in Human Neurons Reveal a Gain-of-function Synaptic Mechanism